Cambridge, UK, Shanghai, China & Melbourne, Australia – 9 September 2013 – SYNthesis med chem, the global contract research organisation providing synthetic and medicinal chemistry services, today announced that the company has opened a new facility at the Babraham Research Campus in Cambridge, UK.
SYNthesis operates a unique business model, combining medicinal chemistry expertise located at the company's labs in Melbourne, Australia and now Cambridge, UK with flexible, high quality, cost effective synthetic chemistry expertise provided by the company's synthetic chemists based in Shanghai, China. The opening of this new facility in Cambridge, UK has enabled SYNthesis to add UK-based medicinal chemistry expertise to the organisation and to provide European customers with local project management for all synthetic and medicinal chemistry projects.
Professor Andrew Wilks, co-founder and Executive Chairman of SYNthesis, commented:
“With an increasing customer base across Europe it was essential that we put in place the infrastructure and resources to deliver the required levels of support for all our medicinal and synthetic chemistry projects. The new Cambridge facility does that, but also gives us the capacity to grow as we attract new customers.”
Dr Xian Bu, co-founder and Managing Director of SYNthesis commented:
“Our “best of both worlds” approach has worked well for SYNthesis over the past six years. It has enabled us to expand our total global chemistry capacity to over 60 chemists and the opening of this new facility in the UK will allow us to take the next step forward. In addition to establishing this new office and labs in Cambridge UK we will be announcing plans for our operations in China later this year.”
Derek Jones of the Babraham Research Campus in Babraham Cambridge UK commented:
“We are delighted that SYNthesis med chem has chosen the Babraham Research Campus as the home for their European operations and we welcome them here at the heart of the Cambridge bio-medical cluster. I am sure that with access to the facilities, resources and community we have on the Babraham Research Campus, and a supportive and entrepreneurial environment in the wider Cambridge region will help ensure that SYNthesis grows and develops their operations successfully.”
Notes to Editors
About SYNthesis med chem
SYNthesis med chem is a global contract research organisation providing synthetic and medicinal services. Established in 2007, the company operates a unique, “best of both worlds” business model combining Western medicinal chemistry expertise with a cost effective and scalable synthetic chemistry capacity based in China.
Locally based medicinal chemistry expertise enables seamless SYNthesis/client communication as well as successful management of all chemistry projects. The company's medicinal chemists, based in Australia and the UK provide the design, innovation, creativity and problem solving expertise required to complement the skills and capabilities of the company's synthetic chemists. SYNthesis medicinal chemists are all experienced and highly skilled scientists with a track record of delivering clinical candidates, a passion for discovering new medicines and a comprehensive insight gained from managing more than 100 projects covering all phases of the pharmaceutical R&D pipeline. They also act as project managers for all custom synthesis and medicinal chemistry projects.
Issued for and on behalf of SYNthesis med chem.